Belzutifan as the first-line treatment for a challenging von Hippel-Lindau-related retinal hemangioblastoma: successful treatment of a case and review of the literature
1 Kellogg Eye Center, University of Michigan, Ann Arbor, MI; Marmara University Medical School, Istanbul, Turkey.
2 Rogel Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI; Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI.
3 Kellogg Eye Center, University of Michigan, Ann Arbor, MI. Electronic address: [email protected].